Skip to main content

Persistent Asset Partners Ltd

Position in APGE — Apogee Therapeutics, Inc.

CIK 2056052 HONG KONG, K3

Position in APGE

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$0
-$184,548 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2024
6 quarters on record

Common Shares in APGE Over Time

Shares Held

Position Value (USD)

Derivatives in APGE

reported options exposure · as of Mar 31, 2026
CallValue
$47,640
CallShares
566
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Persistent Asset Partners Ltd holds $74,585,923 across 142 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in APGE

Export CSV
7 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $47,640 566
2025-12-31 $184,548 2,445
2025-09-30 $588,758 14,819
2025-06-30 $105,317 2,425
2025-03-31 $342,890 9,178
2024-12-31 $2,446 54
2024-12-31 $812,682 17,940